Detail akcie Orion online

Business Summary: Orion Oyj is a Finland-based company engaged in the development, manufacture and marketing of pharmaceuticals and diagnostic tests. The Company operates, along with its subsidiaries, in two business segments: the Pharmaceuticals business segment develops, manufactures and markets pharmaceuticals and active pharmaceutical ingredients, and the Diagnostics business segment develops, manufactures and markets diagnostic tests. The Company’s business comprises two main divisions: Proprietary Products and Specialty Products. Its Proprietary Products consist of patented prescription products in three therapy areas: central nervous system diseases, oncology and critical care, and Easyhaler pulmonary drugs. The Company’s Specialty Products, which include the provision of generic prescription drugs and self-care products for basic healthcare. In addition the Company also produces veterinary medicines for pets and production animals.
Financial Summary: BRIEF: For the three months ended 31 March 2025, Orion Oyj revenues increased 15% to EUR354.6M. Net income applicable to common stockholders increased 40% to EUR61.4M. Revenues reflect Innovative Medicines segment increase of 70% to EUR97.8M, Branded Products segment increase of 10% to EUR77M, Other Europe segment increase of 10% to EUR107.9M, North America segment increase of 17% to EUR54.7M.